Affymax (AFFY) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	3.4M
Short-term investments
Receivable from Takeda
Deferred tax assets
Prepaid expenses and other current assets
Total current assets	4.45M
Property and equipment, net
Restricted cash
Long-term investments
Deferred tax assets, net of current
Other assets	930K
Total assets	5.38M
Accounts payable	80K
Accrued liabilities	69K
Accrued clinical trial expenses
Payable to Takeda
Deferred revenue
Total current liabilities	214K
Long-term income tax liability
Other long-term liabilities
Total liabilities
Commitments and contingencies (Note 6)
Common stock: 35,438,277 and 25,451,338 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively	37K
Additional paid-in capital	557.45M
Accumulated deficit	-552.32M
Accumulated other comprehensive income
Total stockholders' equity
Total liabilities and stockholders' equity	5.38M

Entities mentioned with AFFY

View All Entities